Empresa BioRestorative Therapies, Inc. Other OTC
Acciones
BRTX
US0906554086
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Therapeutic Products and Medical Therapies
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +21,70 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +21,70 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Lance Alstodt
CEO | Chief Executive Officer | 53 | 01/10/18 |
Robert Kristal
DFI | Director of Finance/CFO | - | 04/11/21 |
Compliance Officer | 55 | 01/09/15 | |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 13/04/11 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Patrick Williams
BRD | Director/Board Member | 51 | 29/10/21 |
David Rosa
BRD | Director/Board Member | 59 | 29/10/21 |
Francisco Silva
CTO | Chief Tech/Sci/R&D Officer | 49 | 13/04/11 |
Nickolay Kukekov
BRD | Director/Board Member | 49 | 18/03/21 |
Lance Alstodt
CEO | Chief Executive Officer | 53 | 01/10/18 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 1 398 158 | 0 | 0 | 81,20 % |
Acción B | 1 | 6 769 919 | 5 497 141 ( 81,20 %) | 0 |
Información de la empresa
BioRestorative Therapies, Inc.
40 Marcus Drive Suite 1
11747, Melville
+631 760 8100
http://www.biorestorative.comSector
Varia. 1 de ene. | Capi. | |
---|---|---|
-1,43 % | 103 mil M | |
+8,96 % | 101 mil M | |
+4,40 % | 23,07 mil M | |
-12,15 % | 22,23 mil M | |
-4,36 % | 18,05 mil M | |
-39,98 % | 17,18 mil M | |
-10,04 % | 16,94 mil M | |
+6,79 % | 14,07 mil M | |
+38,61 % | 12,35 mil M |